Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-09-066628
Filing Date
2009-12-29
Accepted
2009-12-29 12:41:53
Documents
5
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 v169993_10k.htm 10-K 1745305
2 v169993_ex31-1.htm EX-31.1 12042
3 v169993_ex31-2.htm EX-31.2 12023
4 v169993_ex32-1.htm EX-32.1 7287
5 v169993_ex32-2.htm EX-32.2 7232
  Complete submission text file 0001144204-09-066628.txt   1785402
Mailing Address 18 TECHNOLOGY, SUITE 130 IRVINE CA 92618
Business Address 18 TECHNOLOGY, SUITE 130 IRVINE CA 92618 949-336-7111
NURX PHARMACEUTICALS, INC. (Filer) CIK: 0001174228 (see all company filings)

EIN.: 870681500 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52037 | Film No.: 091263351
SIC: 2833 Medicinal Chemicals & Botanical Products